hotspot -WSS

hotspot

author：comprehensive 2025-10-01 22:39:25 - browse：83856

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Stigma and the return of syphilis

WSS

Biden administration sends mixed signals on US soldier who crossed into North Korea

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Dark money group runs ads on China biotech bill

Robert Kennedy Jr.'s presidential campaign attracts GOP

15 die by electrocution after transformer explodes in northern India

Insmed lung disease drug hits target in key Phase 3 trial

entertainment

hotspot

entertainment

Psychedelics group wrestles with new pharma identity

A look at other Americans who have crossed into North Korea over the years

Activists slam private health insurers over coverage restrictions

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Apple is now the first public company to be valued at $3 trillion

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Moonlake's readout produced a cash windfall. Risks remain

Startling documents reveal new facets of Sacklers' opioid empire

Hepatitis C has a cure — but many Americans still lack access to it

Health insurers say they are turning to AI to cut costs, improve care

focus

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Biohaven protein

Biden administration sends mixed signals on US soldier who crossed into North Korea

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Childbirth

Stigma and the return of syphilis

leisure time

explore

hotspot

leisure time